Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes.

Jing L, Guigonis JM, Borchiellini D, Durand M, Pourcher T, Ambrosetti D.

Sci Rep. 2019 Oct 30;9(1):15635. doi: 10.1038/s41598-019-52059-y.

2.

Urinary ketone body loss leads to degeneration of brain white matter in elderly SLC5A8-deficient mice.

Suissa L, Flachon V, Guigonis JM, Olivieri CV, Burel-Vandenbos F, Guglielmi J, Ambrosetti D, Gérard M, Franken P, Darcourt J, Pellerin L, Pourcher T, Lindenthal S.

J Cereb Blood Flow Metab. 2019 Sep 10:271678X19873662. doi: 10.1177/0271678X19873662. [Epub ahead of print]

PMID:
31506013
3.

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.

Dufies M, Grytsai O, Ronco C, Camara O, Ambrosetti D, Hagege A, Parola J, Mateo L, Ayrault M, Giuliano S, Grépin R, Lagarde N, Montes M, Auberger P, Demange L, Benhida R, Pagès G.

Theranostics. 2019 Jul 9;9(18):5332-5346. doi: 10.7150/thno.34681. eCollection 2019. Review.

4.

The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells.

Gobbi G, Donati B, Do Valle IF, Reggiani F, Torricelli F, Remondini D, Castellani G, Ambrosetti DC, Ciarrocchi A, Sancisi V.

Oncogene. 2019 Oct;38(42):6801-6817. doi: 10.1038/s41388-019-0924-1. Epub 2019 Aug 12.

PMID:
31406246
5.

Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma.

Antomarchi J, Ambrosetti D, Cohen C, Delotte J, Chevallier A, Karimdjee-Soilihi B, Ngo-Mai M, Schmid-Alliana A, Schmid-Antomarchi H.

Cancer Microenviron. 2019 May 27. doi: 10.1007/s12307-019-00225-1. [Epub ahead of print]

PMID:
31134527
6.

PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.

Kaminski L, Torrino S, Dufies M, Djabari Z, Haider R, Roustan FR, Jaune E, Laurent K, Nottet N, Michiels JF, Gesson M, Rocchi S, Mazure NM, Durand M, Tanti JF, Ambrosetti D, Clavel S, Ben-Sahra I, Bost F.

Cancer Res. 2019 Jul 1;79(13):3268-3280. doi: 10.1158/0008-5472.CAN-18-2043. Epub 2019 May 7.

PMID:
31064849
7.

GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.

Chiche J, Reverso-Meinietti J, Mouchotte A, Rubio-Patiño C, Mhaidly R, Villa E, Bossowski JP, Proics E, Grima-Reyes M, Paquet A, Fragaki K, Marchetti S, Briere J, Ambrosetti D, Michiels JF, Molina TJ, Copie-Bergman C, Lehmann-Che J, Peyrottes I, Peyrade F, de Kerviler E, Taillan B, Garnier G, Verhoeyen E, Paquis-Flucklinger V, Shintu L, Delwail V, Delpech-Debiais C, Delarue R, Bosly A, Petrella T, Brisou G, Nadel B, Barbry P, Mounier N, Thieblemont C, Ricci JE.

Cell Metab. 2019 Jun 4;29(6):1243-1257.e10. doi: 10.1016/j.cmet.2019.02.002. Epub 2019 Feb 28.

PMID:
30827861
8.

Cellular Angiofibroma: Case Report of a Unique Subungual Presentation.

Perrin C, Cannata GE, Pedeutour F, Dadone-Montaudié B, Ambrosetti D.

Acta Derm Venereol. 2019 Sep 1;99(10):915-916. doi: 10.2340/00015555-3152.

9.

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness.

Ndiaye PD, Dufies M, Giuliano S, Douguet L, Grépin R, Durivault J, Lenormand P, Glisse N, Mintcheva J, Vouret-Craviari V, Mograbi B, Wurmser M, Ambrosetti D, Rioux-Leclercq N, Maire P, Pagès G.

Theranostics. 2019 Jan 21;9(3):661-675. doi: 10.7150/thno.27794. eCollection 2019.

10.

UBTD1 is a mechano-regulator controlling cancer aggressiveness.

Torrino S, Roustan FR, Kaminski L, Bertero T, Pisano S, Ambrosetti D, Dufies M, Uhler JP, Lemichez E, Mettouchi A, Gesson M, Laurent K, Gaggioli C, Michiels JF, Lamaze C, Bost F, Clavel S.

EMBO Rep. 2019 Apr;20(4). pii: e46570. doi: 10.15252/embr.201846570. Epub 2019 Feb 25.

PMID:
30804013
11.

Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy.

Lemoine M, François A, Grangé S, Rabant M, Châtelet V, Cassiman D, Cornec-Le Gall E, Ambrosetti D, Deschênes G, Benoist JF, Guerrot D.

Kidney Int Rep. 2018 Jun 8;3(5):1153-1162. doi: 10.1016/j.ekir.2018.05.015. eCollection 2018 Sep.

12.

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.

Dufies M, Nollet M, Ambrosetti D, Traboulsi W, Viotti J, Borchiellini D, Grépin R, Parola J, Giuliano S, Helley-Russick D, Bensalah K, Ravaud A, Bernhard JC, Schiappa R, Bardin N, Dignat-George F, Rioux-Leclercq N, Oudard S, Négrier S, Ferrero JM, Chamorey E, Blot-Chabaud M, Pagès G.

Theranostics. 2018 Mar 28;8(9):2447-2458. doi: 10.7150/thno.23002. eCollection 2018.

13.

STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases.

Fabre A, Marchal S, Forbes LR, Vogel TP, Barlogis V, Triolo V, Rohrlich PS, Bérard E, Frankel D, Ambrosetti D, Soler C, Hoflack M, Baque M, Bosdure E, Baravalle M, Carsin A, Dubus JC, Giovannini-Chami L.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):e22-e23. doi: 10.1164/rccm.201707-1500IM. No abstract available.

PMID:
29590538
14.

Combination of blood and biphasic calcium phosphate microparticles for the reconstruction of large bone defects in dog: A pilot study.

Balaguer T, Fellah BH, Boukhechba F, Traverson M, Mouska X, Ambrosetti D, Dadone B, Michiels JF, Amri EZ, Trojani C, Bouler JM, Gauthier O, Rochet N.

J Biomed Mater Res A. 2018 Jul;106(7):1842-1850. doi: 10.1002/jbm.a.36384. Epub 2018 Mar 24.

PMID:
29573560
15.

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines.

Dufies M, Ambrosetti D, Boulakirba S, Calleja A, Savy C, Furstoss N, Zerhouni M, Parola J, Aira-Diaz L, Marchetti S, Orange F, Lacas-Gervais S, Luciano F, Jacquel A, Robert G, Pagès G, Auberger P.

Oncotarget. 2017 Dec 23;9(13):10920-10933. doi: 10.18632/oncotarget.23650. eCollection 2018 Feb 16.

16.

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.

Ambrosetti D, Dufies M, Dadone B, Durand M, Borchiellini D, Amiel J, Pouyssegur J, Rioux-Leclercq N, Pages G, Burel-Vandenbos F, Mazure NM.

PLoS One. 2018 Feb 26;13(2):e0193477. doi: 10.1371/journal.pone.0193477. eCollection 2018.

17.

ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.

Bodokh Y, Ambrosetti D, Kubiniek V, Tibi B, Durand M, Amiel J, Pertuit M, Barlier A, Pedeutour F.

Cancer Genet. 2018 Feb;221:31-37. doi: 10.1016/j.cancergen.2017.11.010. Epub 2017 Dec 12. Review.

PMID:
29405994
18.

Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.

Mendel L, Ambrosetti D, Bodokh Y, Ngo-Mai M, Durand M, Simbsler-Michel C, Delhorbe M, Amiel J, Pedeutour F.

Genes Chromosomes Cancer. 2018 Mar;57(3):99-113. doi: 10.1002/gcc.22513. Epub 2017 Dec 20. Review.

PMID:
29127730
19.

Sirtuin 7: a new marker of aggressiveness in prostate cancer.

Haider R, Massa F, Kaminski L, Clavel S, Djabari Z, Robert G, Laurent K, Michiels JF, Durand M, Ricci JE, Tanti JF, Bost F, Ambrosetti D.

Oncotarget. 2017 Aug 24;8(44):77309-77316. doi: 10.18632/oncotarget.20468. eCollection 2017 Sep 29.

20.

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.

Dadone-Montaudié B, Ambrosetti D, Dufour M, Darcourt J, Almairac F, Coyne J, Virolle T, Humbert O, Burel-Vandenbos F.

PLoS One. 2017 Sep 22;12(9):e0184625. doi: 10.1371/journal.pone.0184625. eCollection 2017.

21.

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

Dufies M, Giuliano S, Viotti J, Borchiellini D, Cooley LS, Ambrosetti D, Guyot M, Ndiaye PD, Parola J, Claren A, Schiappa R, Gal J, Frangeul A, Jacquel A, Cassuto O, Grépin R, Auberger P, Bikfalvi A, Milano G, Escudier B, Rioux-Leclercq N, Porta C, Negrier S, Chamorey E, Ferrero JM, Pagès G.

Br J Cancer. 2017 Sep 26;117(7):947-953. doi: 10.1038/bjc.2017.276. Epub 2017 Aug 29.

22.

Percutaneous image-guided biopsies of small renal tumors: Current practice and perspectives.

Marcelin C, Ambrosetti D, Bernhard JC, Roy C, Grenier N, Cornelis FH.

Diagn Interv Imaging. 2017 Sep;98(9):589-599. doi: 10.1016/j.diii.2017.07.008. Epub 2017 Aug 24. Review.

23.

Papillomavirus genotyping on formaldehyde fixed paraffin-embedded tissues in vulvar intraepithelial neoplasia.

Mazellier S, Dadone-Montaudie B, Chevallier A, Loubatier C, Vitale S, Cardot-Leccia N, Angeli K, Trastour C, Delotte J, Giordanengo V, Ambrosetti D.

Arch Gynecol Obstet. 2017 Oct;296(4):811-817. doi: 10.1007/s00404-017-4472-z. Epub 2017 Aug 9.

PMID:
28795241
24.

The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells.

Loubiere C, Clavel S, Gilleron J, Harisseh R, Fauconnier J, Ben-Sahra I, Kaminski L, Laurent K, Herkenne S, Lacas-Gervais S, Ambrosetti D, Alcor D, Rocchi S, Cormont M, Michiels JF, Mari B, Mazure NM, Scorrano L, Lacampagne A, Gharib A, Tanti JF, Bost F.

Sci Rep. 2017 Jul 11;7(1):5040. doi: 10.1038/s41598-017-05052-2.

25.

Melanocytes Pattern in the Normal Nail, With Special Reference to Nail Bed Melanocytes.

Perrin C, Michiels JF, Boyer J, Ambrosetti D.

Am J Dermatopathol. 2018 Mar;40(3):180-184. doi: 10.1097/DAD.0000000000000940.

PMID:
28692464
26.

Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma.

Lupu-Plesu M, Claren A, Martial S, N'Diaye PD, Lebrigand K, Pons N, Ambrosetti D, Peyrottes I, Feuillade J, Hérault J, Dufies M, Doyen J, Pagès G.

Oncogenesis. 2017 Jul 3;6(7):e354. doi: 10.1038/oncsis.2017.56.

27.

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.

Dufies M, Giuliano S, Ambrosetti D, Claren A, Ndiaye PD, Mastri M, Moghrabi W, Cooley LS, Ettaiche M, Chamorey E, Parola J, Vial V, Lupu-Plesu M, Bernhard JC, Ravaud A, Borchiellini D, Ferrero JM, Bikfalvi A, Ebos JM, Khabar KS, Grépin R, Pagès G.

Cancer Res. 2017 Mar 1;77(5):1212-1226. doi: 10.1158/0008-5472.CAN-16-3088. Epub 2017 Jan 13.

28.

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.

Guyot M, Hilmi C, Ambrosetti D, Merlano M, Lo Nigro C, Durivault J, Grépin R, Pagès G.

Oncotarget. 2017 Feb 7;8(6):9174-9188. doi: 10.18632/oncotarget.13942.

29.

Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment.

Lhermitte B, Egele C, Weingertner N, Ambrosetti D, Dadone B, Kubiniek V, Burel-Vandenbos F, Coyne J, Michiels JF, Chenard MP, Rouleau E, Sabourin JC, Bellocq JP.

Virchows Arch. 2017 Jan;470(1):21-27. doi: 10.1007/s00428-016-2042-6. Epub 2016 Nov 16.

PMID:
27853865
30.

CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review.

Cornelis F, Ambrosetti D, Rocher L, Derchi LE, Renard B, Puech P, Claudon M, Rouvière O, Ferlicot S, Roy C, Yacoub M, Grenier N, Bernhard JC.

Eur Radiol. 2017 Mar;27(3):1087-1095. doi: 10.1007/s00330-016-4469-1. Epub 2016 Jun 22.

PMID:
27334016
31.

Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.

Benhamou Y, Picco V, Raybaud H, Sudaka A, Chamorey E, Brolih S, Monteverde M, Merlano M, Lo Nigro C, Ambrosetti D, Pagès G.

Oncotarget. 2016 Jul 12;7(28):44236-44251. doi: 10.18632/oncotarget.10005.

32.

Acquired Localized (Monodactylous) Longitudinal Pachyonychia and Onychocytic Carcinoma In Situ (2 Cases): Part II.

Perrin C, Cannata GE, Ambrosetti D, Patouraux S, Langbein L, Schweizer J.

Am J Dermatopathol. 2017 Jan;39(1):40-44. doi: 10.1097/DAD.0000000000000579.

PMID:
27219353
33.

Acquired Localized Longitudinal Pachyonychia and Onychomatrical Tumors: A Comparative Study to Onychomatricomas (5 Cases) and Onychocytic Matricomas (4 Cases).

Perrin C, Cannata GE, Langbein L, Ambrosetti D, Coutts M, Balaguer T, Garzon JM, Michiels JF.

Am J Dermatopathol. 2016 Sep;38(9):664-71. doi: 10.1097/DAD.0000000000000511.

PMID:
26978004
34.

Trichosporon fungemia in a pediatric patient with acute lymphoblastic leukemia.

Maxfield L, Matthews JJ, Ambrosetti DR, Ephtimios IE.

IDCases. 2015 Sep 30;2(4):106-8. doi: 10.1016/j.idcr.2015.09.007. eCollection 2015.

35.

Infections related to Actinotignum schaalii (formerly Actinobaculum schaalii): a 3-year prospective observational study on 50 cases.

Lotte L, Lotte R, Durand M, Degand N, Ambrosetti D, Michiels JF, Amiel J, Cattoir V, Ruimy R.

Clin Microbiol Infect. 2016 Apr;22(4):388-390. doi: 10.1016/j.cmi.2015.10.030. Epub 2015 Nov 10. No abstract available.

36.

Évaluation du profil plasmatique des microARNs, comme marqueur diagnostic du cancer localisé de la prostate avec confirmation des analyses par prélèvement tissulaire sur spécimens après prostatectomie radicale élargie.

Tibi B, Durand M, Rouscoff Y, Lee J, Mauduit C, Ambrosetti D, Mahate Z, Wijeratne V, Severac F, Carpentier X, Marsaud A, Mentine N, Quintens H, Amiel J, Chevallier D, Benahmed M.

Prog Urol. 2014 Nov;24(13):787-8. doi: 10.1016/j.purol.2014.08.014. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461539
37.

Endothelial Cells Promote Pigmentation through Endothelin Receptor B Activation.

Regazzetti C, De Donatis GM, Ghorbel HH, Cardot-Leccia N, Ambrosetti D, Bahadoran P, Chignon-Sicard B, Lacour JP, Ballotti R, Mahns A, Passeron T.

J Invest Dermatol. 2015 Dec;135(12):3096-3104. doi: 10.1038/jid.2015.332. Epub 2015 Aug 26.

38.

Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis.

Tichet M, Prod'Homme V, Fenouille N, Ambrosetti D, Mallavialle A, Cerezo M, Ohanna M, Audebert S, Rocchi S, Giacchero D, Boukari F, Allegra M, Chambard JC, Lacour JP, Michiels JF, Borg JP, Deckert M, Tartare-Deckert S.

Nat Commun. 2015 Apr 30;6:6993. doi: 10.1038/ncomms7993.

PMID:
25925867
39.

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.

Marsaud A, Dadone B, Ambrosetti D, Baudoin C, Chamorey E, Rouleau E, Lefol C, Roussel JF, Fabas T, Cristofari G, Carpentier X, Michiels JF, Amiel J, Pedeutour F.

Genes Chromosomes Cancer. 2015 Jun;54(6):369-82. doi: 10.1002/gcc.22248. Epub 2015 Mar 28.

PMID:
25820192
40.

Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2.

Sancisi V, Gandolfi G, Ambrosetti DC, Ciarrocchi A.

Cancer Res. 2015 May 1;75(9):1868-82. doi: 10.1158/0008-5472.CAN-14-2087. Epub 2015 Mar 13.

41.

[Elastography shows promise in testicular cancer detection].

Marsaud A, Durand M, Raffaelli C, Carpentier X, Rouscoff Y, Tibi B, Floc'h A, De Villeneuve MH, Haider R, Ambrosetti D, Fontas E, Padovani B, Amiel J, Chevallier D.

Prog Urol. 2015 Feb;25(2):75-82. doi: 10.1016/j.purol.2014.11.008. Epub 2014 Dec 30. French.

PMID:
25555503
42.

L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.

Rosilio C, Nebout M, Imbert V, Griessinger E, Neffati Z, Benadiba J, Hagenbeek T, Spits H, Reverso J, Ambrosetti D, Michiels JF, Bailly-Maitre B, Endou H, Wempe MF, Peyron JF.

Leukemia. 2015 Jun;29(6):1253-66. doi: 10.1038/leu.2014.338. Epub 2014 Dec 8.

PMID:
25482130
43.

The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter.

El Maï M, Wagner KD, Michiels JF, Ambrosetti D, Borderie A, Destree S, Renault V, Djerbi N, Giraud-Panis MJ, Gilson E, Wagner N.

Cell Rep. 2014 Nov 6;9(3):1047-60. doi: 10.1016/j.celrep.2014.09.038. Epub 2014 Oct 23.

44.

Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.

Vassallo M, Moranne O, Ambrosetti D, Jeandel PY, Pomares C, Cassuto E, Boscagli A, Giraud G, Montagne N, Dentone C, Demacina I, Villaggio B, Secondo G, Ferrea G, Passeron C, Saudes L, Kaphan R, Marty P, Rosenthal E.

BMC Infect Dis. 2014 Oct 30;14:561. doi: 10.1186/s12879-014-0561-9.

45.

[Salvage HIFU after radiotherapy and salvage radiotherapy after HIFU in locally recurrent prostate cancer: Retrospective analysis of morbidity].

Lee JW, Chevallier D, Gal J, Rouscoff Y, Natale R, Chand ME, Raffaelli C, Ambrosetti D, Durand M, Amiel J, Hannoun-Levi JM.

Prog Urol. 2014 Dec;24(16):1076-85. doi: 10.1016/j.purol.2014.08.235. Epub 2014 Sep 18. French.

PMID:
25241245
46.

Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.

Seitz-Polski B, Payré C, Ambrosetti D, Albano L, Cassuto-Viguier E, Berguignat M, Jeribi A, Thouret MC, Bernard G, Benzaken S, Lambeau G, Esnault VL.

Nephrol Dial Transplant. 2014 Dec;29(12):2334-42. doi: 10.1093/ndt/gfu252. Epub 2014 Jul 25.

PMID:
25063424
47.

Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.

Schmeiser HH, Nortier JL, Singh R, Gamboa da Costa G, Sennesael J, Cassuto-Viguier E, Ambrosetti D, Rorive S, Pozdzik A, Phillips DH, Stiborova M, Arlt VM.

Int J Cancer. 2014 Jul 15;135(2):502-7.

48.

Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure.

Duteil L, Cardot-Leccia N, Queille-Roussel C, Maubert Y, Harmelin Y, Boukari F, Ambrosetti D, Lacour JP, Passeron T.

Pigment Cell Melanoma Res. 2014 Sep;27(5):822-6. doi: 10.1111/pcmr.12273. Epub 2014 Jul 25.

PMID:
24888214
49.

Fetal retained lung fluid: not always bilateral.

Alauzet F, Ambrosetti D, Geoffray A, Devred P, Dubus JC, Giovannini-Chami L.

J Pediatr. 2014 Jun;164(6):1498-1498.e1. doi: 10.1016/j.jpeds.2014.02.049. Epub 2014 Mar 31. No abstract available.

PMID:
24698451
50.

The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Grépin R, Ambrosetti D, Marsaud A, Gastaud L, Amiel J, Pedeutour F, Pagès G.

PLoS One. 2014 Mar 27;9(3):e89449. doi: 10.1371/journal.pone.0089449. eCollection 2014.

Supplemental Content

Loading ...
Support Center